Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive ...

New research suggests that men who take multivitamins after being diagnosed with prostate cancer may have a lower risk of cancer recurrence. In the overall study group, current multivitamin users ...

Pfizer PFE reported positive top-line results from a late-stage study evaluating Talzenna (talazoparib), an oral PARP ...

Cannabis each day keeps prostate cancer away: Prostate cancer (PC) prevalence was lower in both current and former cannabis users compared to non-users in a recent study. Alternative medicines are ...

What if a medicine you thought of as “old news” suddenly showed up in new research with fresh benefits that might stretch ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI ...

Long-term use of acetaminophen is associated with a decreased risk of prostate cancer (PCa), according to a study. Previous epidemiologic studies have shown that use of aspirin and other nonsteroidal ...

Prostate cancer is the second-leading cause of cancer deaths in American men. Further, non-Hispanic Blacks have a higher incidence of prostate cancer and are more likely to die from it than are ...

Just over half (56%) of men with prostate cancer in a large study reported using complementary and alternative medicine (CAM), and the study also found that use of these products has been increasing ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.